Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Apr 26, 2007 12:23pm
350 Views
Post# 12679712

RE: Fimat

RE: FimatFIMAT started trading RVX on Feb 1/07. Since that date here's what they've done: Sold..: 158,900 shares for $3,126,723 Bought: 155,900 shares for $3,060,584 Difference is -3000 shares meaning they're short 3000 shares. Difference in money is $66,139 to the good. Subtract the cost of covering the short at today's price: 3000 shares x $16.50 = $49,500 So the profit for FIMAT since Feb 1 is $66,139 - $49,500 = $16,639. That means that in 3 months using over $3 million on each side of its trades, handling over $6 million in other words, FIMAT made a profit before commissions and expenses of only $16,639. They made no profit, in other words. Lurking brags about making this much over lunch. RVX is the easiest stock on the planet to day trade. So why has FIMAT failed so miserably to make a profit. They're controlling the market for 1 or more other accounts, maybe National, certainly another one or more that remains anonymous. Every bid and offer that FIMAT puts up is meant to make RVX "look" a certain way, moving up, moving down, whatever. They will even buy to make the market look like it's dropping. They just put 100 shares above the top bid as bait. Anybody who wants to sell usually has more than 100 shares to sell so a sale goes through, knocks out the FIMAT bait bid and takes out the next lowest bid resulting in a dropping stock. They can walk it down at will that way. FIMAT is running the market, sweetest moving box you ever saw and they've got investors totally hypnotized.
Bullboard Posts